Using unregulated peptides without medical supervision carries real safety risks
A 2003 study by Staresinic, Sebecic, Patrlj, and colleagues in Journal of Orthopaedic Research used a rat Achilles tendon transection model with BPC-157 administered intraperitoneally once daily at 10 g/kg, 10 ng/kg, or 10 pg/kg and reported improved load-to-failure, Young's modulus of elasticity, and Achilles functional index scores, reduced tendon defect size by day 14, and increased tendocyte outgrowth in vitro with specific numerical effect sizes and p-values not reported in the abstract
All samples were collected with the patients written informed consent
See Perfect Bs full peptide treatment plan in Doral, FL, including all eight peptide options, protocol structures, and how multi-peptide stacks are built around each patients clinical goals
Mc Carthy DJ, Malhotra M, OMahony AM, Cryan JF, ODriscoll CM